Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

Boehringer's classical swine fever live vaccine approved
CSF has caused huge economic losses to China's pig farming industry.
Vaccine will play a vital role in eradicating the disease in China.

The first classical swine fever (CSF) live vaccine, jointly developed by Boehringer Ingelheim and Chinese research institutes, has received marketing approval.

The newly-approved Ingelvac CSF MLV is set to provide China's swine industry with breakthrough immunization programmes and support disease solutions. It will also play a vital role in eradicating CSF in the country.

CSF is a highly contagious, lethal disease that has caused huge economic losses to China's pig farming industry. While the outbreak is now effectively controlled by mass vaccination with CSF live vaccine, endemic and sporadic spread remains.

Existing CSF live vaccines can only be stored at -15℃  for 18 months, with strict temperature control requires for transportation, storage and dilution. The new vaccine uses state-of-the-art suspension culture and freeze-drying technologies to ensure stable vaccine production process, and controllable quality. It can be stored at 2-8℃ for 24 months.

In a press release, a Boehringer spokesperson said the vaccine ' marks another milestone for Boehringer Ingelheim’s “in China, for China”, as the company is committed to providing innovative and high-quality swine vaccines for the Chinese swine industry, as well as holistic swine disease solutions to pig farms.'

Ingelvac® CSF MLV will be produced by Boehringer Ingelheim’s Taizhou plant and is expected to be commercialised in early 2021. 

Become a member or log in to add this story to your CPD history

Kennel Club appoints new chief executive

News Story 1
 The Kennel Club has announced the appointment of Mark Beazley, who was previously Cats Protection's director of operations, as chief executive. Mark replaces Rosemary Smart, who stepped down from the role in April after 18 years.

Mark has held several senior strategic and executive roles, including executive director at Dogs Trust Ireland and chair of the Companion Animal Working Group at Eurogroup for Animals. He was also heavily involved in the establishment of the Eu Cat and Dog Alliance.

Mark will take up his new role in October. 

Click here for more...
News Shorts
International Cat Care appoints new head of veterinary division

International Cat Care (ICC) has announced the appointment of Nathalie Dowgray as head of the charity's veterinary division.

Nathalie, who is an RCVS advanced practitioner in feline medicine, will lead the International Society of Feline Medicine (ISFM) and a play key role in advancing knowledge and research in feline medicine.

Claire Bessant, iCatCare's chief executive said: "We're absolutely delighted to be welcoming Nathalie to the charity. She brings a depth and breadth of feline expertise and understanding which fits perfectly with the charity's work and development, and her enthusiasm for cats is infectious."